Network based approach identifies miR ‐145‐3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma
The Journal of Pathology · 2026-12 · 270 (4) · 468-480
DOI: 10.1002/path.70116 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 09.09.2026. Verfasst von Anna Citarella und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Health, and Health Professions, Link Campus University, Rome, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Thyroid Neoplasms, Carcinoma, Neuroendocrine, Gene Regulatory Networks. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Sapienza Università di Roma.
Abstract (Originalsprache)
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor originating from calcitonin producing C‐cells and accounts for 1–5% of thyroid cancers. Total thyroidectomy is curative in localized disease (N0), whereas lymph node metastases (N1) are associated with poorer prognosis. However, the molecular mechanisms driving the metastatic shift remain poorly understood. This study aimed to identify miRNA features linked to metastatic spread in MTC, focusing on the transition from N0 to N1. Co‐expression networks were constructed for N0 and N1 tumors, and differential connectivity analysis was used to identify key miRNAs acting as regulatory hubs. Functional annotation of their target genes was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and Reactome pathway analyses. Validation experiments were carried out in MTC cells to evaluate the effects of selected miRNAs on cell proliferation, survival, and MAPK pathway activation. Network analysis revealed distinct miRNA co‐expression patterns between N0 and N1 tumors. Differential network analysis highlighted miR‐145‐3p as a central regulatory hub, exhibiting 29 altered co‐expression changes and a marked loss of connectivity in N1. Target enrichment identified 59 validated genes, including key oncogenic drivers such as MYC , PTEN , BCL2 , PIK3CA , AKT1 , and MAPK7 . In MTC cells, simultaneous inhibition of miR‐145‐3p together with its top co‐expressed miRNAs increased proliferation and survival, and enhanced ERK phosphorylation, indicating MAPK pathway activation and a shift toward a more aggressive phenotype. In conclusion, this study identifies a miRNA regulatory hub centered on miR‐145‐3p that is associated with metastatic progression and highlights the value of network‐based approaches in uncovering mechanisms of cancer dissemination. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science, Health, and Health Professions, Link Campus University, Rome, Italy.
- Department of Computer, Control and Management Engineering, Sapienza University of Rome, Rome, Italy.
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
- Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata, (IRCCS-CROB), Rionero in Vulture (Potenza), Italy.
- Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy.
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
ORCID-Profile: Anna Citarella, Manuela Petti, Zein Mersini Besharat, Caterina Alfano, Sara Cassandro, Claudia Sabato, Francesca Gianno, Tanja Milena Autilio, Giuseppina Catanzaro, Antonella Verrienti, Cristina Romei, Maria Grazia Castagna, Silvia Cantara, Vincenzo Marotta, Lorenzo Farina, Cosimo Durante, Agnese Po, Elisabetta Ferretti
Förderung
- Ministero dell'Università e della Ricerca
- Sapienza Università di Roma
Zitieren
APA
Citarella, A., Petti, M., Besharat, Z. M., Alfano, C., Splendiani, E., Trocchianesi, S., Cassandro, S., Chiacchiarini, M., Sabato, C., Gianno, F., Autilio, T. M., Brunetti, M., Catanzaro, G., Verrienti, A., Elisei, R., Ciampi, R., Romei, C., Castagna, M. G., Cantara, S., …, & Ferretti, E. (2026). Network based approach identifies miR ‐145‐3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma. The Journal of Pathology, 270(4), 468-480. https://doi.org/10.1002/path.70116
Vancouver
Citarella A, Petti M, Besharat ZM, Alfano C, Splendiani E, Trocchianesi S, et al. Network based approach identifies miR ‐145‐3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma. The Journal of Pathology. 2026;270(4):468-480. doi:10.1002/path.70116
BibTeX
@article{Citarella2026,
author = {Citarella, Anna and Petti, Manuela and Besharat, Zein Mersini and Alfano, Caterina and Splendiani, Elena and Trocchianesi, Sofia and Cassandro, Sara and Chiacchiarini, Martina and Sabato, Claudia and Gianno, Francesca and Autilio, Tanja Milena and Brunetti, Martina and Catanzaro, Giuseppina and Verrienti, Antonella and Elisei, Rossella and Ciampi, Raffaele and Romei, Cristina and Castagna, Maria Grazia and Cantara, Silvia and Marotta, Vincenzo and Pezzullo, Luciano and Farina, Lorenzo and Durante, Cosimo and Po, Agnese and Ferretti, Elisabetta},
title = {Network based approach identifies miR ‐145‐3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma},
journal = {The Journal of Pathology},
year = {2026},
volume = {270},
number = {4},
pages = {468--480},
doi = {10.1002/path.70116}
}
EUVIMED